Method of identifying when a patient undergoing hemodialysis is at increased risk of death
US9883799B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2010 |
| Grant date | Feb 6, 2018 |
| Priority date | — |
| Expiry date | Dec 20, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B5/021
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The invention is directed to a method of identifying a patient undergoing periodic hemodialysis treatments at increased risk for death that includes determining at least one of the patient's clinical or biochemical parameters, including systolic blood pressure, serum albumin concentration level, body weight, body temperature, serum bicarbonate concentration level, serum potassium concentration level, serum calcium concentration level, hemoglobin concentration level, serum phosphorus concentration level, neutrophil to lymphocyte ratio, equilibrated normalized protein catabolic rate (enPCR), equilibrated fractional clearance of total body water by dialysis and residual kidney function (eKdrt/V), EPO resistance index, transferrin saturation index, serum ferritin concentration level, serum creatinine concentration level, platelet count, Aspartat-Aminotransferase level, and Alanin-Aminotransferase level at periodic hemodialysis treatments, and identifying a patient as having an increased risk for death if the patient has a significant change in the rate of change of at least one of the patient's clinical or biochemical parameters. The invention is also directed to a method of identifyin…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.